We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
-5.19%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$586M
AUM Growth
+$27.7M
Cap. Flow
+$76.8M
Cap. Flow %
13.1%
Top 10 Hldgs %
4.62%
Holding
2,170
New
811
Increased
351
Reduced
336
Closed
665

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$3.33M
2
LLY icon
Eli Lilly
LLY
+$3.21M
3
GWW icon
W.W. Grainger
GWW
+$2.81M
4
ATVI
Activision Blizzard
ATVI
+$2.81M
5
V icon
Visa
V
+$2.72M

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$2.68M
2
NDAQ icon
Nasdaq
NDAQ
+$2.22M
3
ORCL icon
Oracle
ORCL
+$2.22M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.98M
5
DE icon
Deere & Co
DE
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 19.51%
2 Technology 18.98%
3 Industrials 14.56%
4 Consumer Discretionary 12.64%
5 Financials 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIFR
276
XPLR Infrastructure LP
XIFR
$1.18B
$618K 0.11%
20,799
+8,992
+76% +$455K
YOU icon
277
Clear Secure
YOU
$5.26B
$614K 0.1%
+32,230
New +$714K
PNNT
278
Pennant Park Investment Corp
PNNT
$215M
$613K 0.1%
93,168
+32,799
+54% +$213K
KRTX
279
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$612K 0.1%
3,619
+1,593
+79% +$300K
TK icon
280
Teekay
TK
$975M
$610K 0.1%
98,879
+6,860
+7% +$43.8K
CRM icon
281
Salesforce
CRM
$134B
$610K 0.1%
3,006
-6,305
-68% -$1.36M
CNXC icon
282
Concentrix
CNXC
$1.36B
$609K 0.1%
+7,604
New +$597K
TTEK icon
283
Tetra Tech
TTEK
$8.23B
$608K 0.1%
+19,995
New +$650K
FCN icon
284
FTI Consulting
FCN
$4.82B
$608K 0.1%
3,407
+1,808
+113% +$337K
INCY icon
285
Incyte
INCY
$23.5B
$607K 0.1%
10,504
+3,163
+43% +$199K
UMBF icon
286
UMB Financial
UMBF
$10.7B
$606K 0.1%
+9,760
New +$634K
SM icon
287
SM Energy
SM
$7.96B
$606K 0.1%
+15,272
New +$579K
CBU icon
288
Community Bank
CBU
$3.53B
$605K 0.1%
14,338
+5,630
+65% +$267K
EXAS
289
DELISTED
Exact Sciences
EXAS
$605K 0.1%
8,867
-2,040
-19% -$173K
GILD icon
290
Gilead Sciences
GILD
$161B
$605K 0.1%
8,070
-2,185
-21% -$168K
FSLR icon
291
First Solar
FSLR
$21.8B
$604K 0.1%
3,740
+183
+5% +$34.1K
ALKS icon
292
Alkermes
ALKS
$8.82B
$604K 0.1%
21,564
+8,071
+60% +$237K
DXCM icon
293
DexCom
DXCM
$27.6B
$602K 0.1%
6,447
+1,864
+41% +$210K
QTWO icon
294
Q2 Holdings
QTWO
$3.42B
$601K 0.1%
+18,612
New +$617K
AWI icon
295
Armstrong World Industries
AWI
$6.86B
$600K 0.1%
8,327
+5,134
+161% +$383K
PODD icon
296
Insulet
PODD
$11.3B
$599K 0.1%
3,754
-1,299
-26% -$291K
BLBD icon
297
Blue Bird Corp
BLBD
$2.41B
$596K 0.1%
27,900
+2,795
+11% +$59.2K
TDY icon
298
Teledyne Technologies
TDY
$30.4B
$595K 0.1%
+1,456
New +$591K
ENB icon
299
Enbridge
ENB
$124B
$595K 0.1%
+17,922
New +$636K
EGP icon
300
EastGroup Properties
EGP
$11.5B
$595K 0.1%
3,571
+634
+22% +$112K

Similar funds

XTX Topco's Q3 2023 Portfolio in Review

As of Q3 2023, XTX Topco held 2,170 positions worth $586M, up 5% from $558M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

XTX Topco deployed $76.8M of net new capital in Q3 2023, opening 811 new positions and adding to 351 existing holdings. Its largest new stake was Idexx Laboratories: 6,687 shares worth $2.92M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Nasdaq, an estimated $2.22M trimmed.

  • XTX Topco's largest Q3 2023 buy was Idexx Laboratories: 6,687 shares worth $2.92M.
  • XTX Topco added most to Microsoft in Q3 2023, an estimated $2.27M increase.
  • XTX Topco's biggest Q3 2023 reduction was Nasdaq, cutting an estimated $2.22M.
  • XTX Topco fully exited Boeing in Q3 2023, selling an estimated $2.68M.
  • XTX Topco's ten largest holdings make up 4.6% of its $586M portfolio in Q3 2023.
  • XTX Topco opened 811 new positions and closed 665 in Q3 2023.
  • XTX Topco's portfolio value rose 5% quarter-over-quarter to $586M.

Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.